Pathstone Family Office, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.33 - $8.76 $3,330 - $8,760	-1,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.31 - $6.54 $3,310 - $6,540	-1,000 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$2.9 - $6.16 $2,900 - $6,160	1,000 New	1,000 $4,000
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $5,610 - $8,570	-1,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$7.56 - $15.44 $7,560 - $15,440	1,000 New	1,000 $8,000
Q2 2019 Aug 14, 2019	SELL	$5.4 - $15.5 $5,400 - $15,500	-1,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.6 - $6.22 $3,600 - $6,220	1,000 New	1,000 $5,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.